# Immunosurveillance for Metastatic Colorectal Cancer

> **NCT06509880** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **MIPO Clinic** · enrollment: 200 (actual)

## Conditions studied

- Monitoring, Immunologic

## Interventions

- **DIETARY_SUPPLEMENT:** Adenorine
- **BIOLOGICAL:** Placebo
- **DRUG:** FOLFOX regimen

## Key facts

- **NCT ID:** NCT06509880
- **Lead sponsor:** MIPO Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-07-15
- **Primary completion:** 2024-07-25
- **Final completion:** 2024-07-31
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2024-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06509880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06509880, "Immunosurveillance for Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06509880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*